Breaking News, Collaborations & Alliances

MannKind Earns $50M Sanofi Milestone

Achieves manufacturing milestone for Afrezza

MannKind Corp. has earned a $50 million milestone payment under its collaboration and licensing agreement with Sanofi in connection with the satisfaction of manufacturing milestones for Afrezza.
 
MannKind had received a $150 million upfront payment and is eligible to earn as much as $725 million in further development, regulatory and sales milestones, and is also eligible to receive a share of profits on Afrezza sales.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters